Sourcing and managing high-cost specialty medications can be challenging, especially when balancing speed, compliance, and affordability. At ExhaleRx, we simplify that process for PBMs, self-funded employer groups, DPC networks, and brokers — providing reliable access to branded therapies with unmatched savings and delivery precision.
💊 Branded Medications We Support
ExhaleRx specializes in fulfillment and logistics for a wide range of branded specialty and chronic-care therapies, including:
- Enbrel (Etanercept) – 50mg SureClick pens and prefilled syringes
- Skyrizi (Risankizumab) – 150mg and 360mg autoinjectors
- Rinvoq (Upadacitinib) – 15mg and 30mg tablets
- Humira (Adalimumab) – 40mg and 80mg pens
- Dupixent (Dupilumab) – 300mg/2mL prefilled pens
- Stelara, Taltz, Cimzia, and Orencia – key biologic injectables
- GLP-1s – including Mounjaro, Ozempic, and Wegovy, for diabetes and weight management programs
We supply only branded medications, ensuring the highest standards of quality and authenticity.
⚙️ How ExhaleRx Delivers
Our streamlined fulfillment model is designed for efficiency, transparency, and patient safety.
📦 Average Delivery Time: 36 Hours Nationwide
❄️ Cold-Chain Packaging: Full temperature control from origin to doorstep
📑 End-to-End Coordination: From provider prescription to patient delivery
🔎 Real-Time Tracking: Full visibility for partners and patients
💡 Why Partners Choose ExhaleRx
✅ Access to hard-to-source branded specialty medications
✅ Up to 80% savings compared to traditional U.S. wholesale channels
✅ Dedicated account management and concierge-level support
✅ Transparent communication and shipment tracking
✅ Built for PBMs, DPCs, self-funded plans, and brokers
✅ Reliable cold-chain logistics and compliance oversight
🌐 Our Mission
At ExhaleRx, we’re committed to improving access to branded specialty and chronic-care medications by delivering speed, value, and precision — without compromising on quality or compliance.
#ExhaleRx #SpecialtyPharmacy #GLP1 #Enbrel #Skyrizi #Rinvoq #Humira #Dupixent #Stelara #Cimzia #Ozempic #Wegovy #Mounjaro #SelfFundedPlans #PBMs #DPC #ChronicCare #DiabetesManagement #PharmaSavings #ColdChain #HealthcareInnovation #PharmacyLogistics #BrandedMedications #PatientCare #HealthcareSavings #BenefitOptimization #EmployeeHealth #AffordableHealthcare #IntegratedCare
